age-related macular degeneration, branch retinal vein occlusion, pathologic myopia, diabetic retinopathy
Conditions
Interventions
None listed
Sponsors
Others
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Subjects diagnosed with choroidal neovascularization associated with age-related macular degeneration, macular edema associated with retinal vein occlusion, choroidal neovascularization in pathological myopia, or diabetic macular edema (because intravitreal drugs including anti-VEGF drugs may be administered). 2. Subjects who are able to visit the hospital during the study period (because it is necessary to continue to visit the hospital for at least one year). 3. Subjects who need to receive a new intravitreal drug including anti-VEGF drugs (because the data required for this study cannot be obtained if the drug has been administered even once at another hospital). 4. The lower limit of the subjects' age was set at 20 years and the upper limit at 90 years (because continuous outpatient visits for one year were considered possible.)
Exclusion criteria
Exclusion criteria: Pregnant women or women who may be pregnant.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Urinary Albumin Quantitative Changes | — |
Secondary
| Measure | Time frame |
|---|---|
| Incidence of advanced urinary albumin determination | — |
Countries
Japan
Contacts
Public ContactNorimitsu Ban
Keio University School of Medicine Department of Ophthalmology
Outcome results
None listed